DK2113502T3 - Hydrazidforbindelser og anvendelse deraf i farmaceutiske sammensætninger til behandling af hjerte-karsygdomme - Google Patents
Hydrazidforbindelser og anvendelse deraf i farmaceutiske sammensætninger til behandling af hjerte-karsygdommeInfo
- Publication number
- DK2113502T3 DK2113502T3 DK09166657.8T DK09166657T DK2113502T3 DK 2113502 T3 DK2113502 T3 DK 2113502T3 DK 09166657 T DK09166657 T DK 09166657T DK 2113502 T3 DK2113502 T3 DK 2113502T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- pharmaceutical compositions
- cardiovascular disease
- hydrazide
- hydrazide compounds
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- GZAMHVSGBNTFCB-UHFFFAOYSA-N 2-cyclopropyl-N-[(2-hydroxy-4,6-dimethoxyphenyl)methylideneamino]quinoline-4-carboxamide Chemical compound COC1=CC(OC)=CC(O)=C1C=NNC(=O)C1=CC(C2CC2)=NC2=CC=CC=C12 GZAMHVSGBNTFCB-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 101001074035 Homo sapiens Zinc finger protein GLI2 Proteins 0.000 abstract 1
- 102000004895 Lipoproteins Human genes 0.000 abstract 1
- 108090001030 Lipoproteins Proteins 0.000 abstract 1
- 102100035558 Zinc finger protein GLI2 Human genes 0.000 abstract 1
- 238000009825 accumulation Methods 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000001539 anorectic effect Effects 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 230000002402 anti-lipaemic effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000001966 cerebroprotective effect Effects 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001553 hepatotropic effect Effects 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003367 polycyclic group Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
- C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0400913A FR2865732B1 (fr) | 2004-01-30 | 2004-01-30 | Composes de type hydrazide et leur utilisation dans des compositions pharmaceutiques pour le traitement des maladies cardiovasculaires |
| EP05717518A EP1709027B1 (fr) | 2004-01-30 | 2005-01-31 | Composes de type hydrazide et leur utilisation dans des compositions pharmaceutiques pour le traitement des maladies cardiovasculaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2113502T3 true DK2113502T3 (da) | 2013-02-18 |
Family
ID=34746342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09166657.8T DK2113502T3 (da) | 2004-01-30 | 2005-01-31 | Hydrazidforbindelser og anvendelse deraf i farmaceutiske sammensætninger til behandling af hjerte-karsygdomme |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070161697A1 (https=) |
| EP (2) | EP2113502B1 (https=) |
| JP (1) | JP5047629B2 (https=) |
| CN (1) | CN100588655C (https=) |
| AT (1) | ATE444961T1 (https=) |
| AU (1) | AU2005217174B2 (https=) |
| BR (1) | BRPI0507248A (https=) |
| CA (1) | CA2554439A1 (https=) |
| DE (1) | DE602005017007D1 (https=) |
| DK (1) | DK2113502T3 (https=) |
| ES (2) | ES2398479T3 (https=) |
| FR (1) | FR2865732B1 (https=) |
| PT (2) | PT1709027E (https=) |
| WO (1) | WO2005082882A1 (https=) |
| ZA (1) | ZA200606909B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006132583A1 (en) * | 2005-06-07 | 2006-12-14 | Innate Pharmaceuticals Ab | Method and means for preventing and inhibiting respiratory disease, atherosclerosis and osteoporosis caused by chlamydia pneumoniae infection |
| EP2338879A1 (en) | 2009-12-15 | 2011-06-29 | Arteria | New phenylhydrazone derivatives and their use as pharmaceuticals |
| WO2012027548A1 (en) * | 2010-08-25 | 2012-03-01 | The Feinstein Institute For Medical Research | Compounds and methods for prevention and treatment of alzheimer's and other diseases |
| CN103044284A (zh) * | 2011-10-13 | 2013-04-17 | 南京大学 | 香草酸酰腙类衍生物及其制备和用途 |
| WO2014028946A2 (en) * | 2012-08-17 | 2014-02-20 | The Broad Institute, Inc. | Modulators of hepatic lipoprotein metabolism |
| CN103613514B (zh) * | 2013-10-30 | 2015-05-13 | 西北师范大学 | 荧光比色识别氰根离子的有机双金属凝胶及其制备和应用 |
| CN104860866B (zh) * | 2015-05-25 | 2018-07-17 | 厦门大学 | 5-(取代碳酰氨基)-1h-吲哚-2-碳酰肼衍生物及其制备方法和应用 |
| CN104829597B (zh) * | 2015-05-25 | 2018-07-17 | 厦门大学 | 1h-吲哚-2-碳酰肼衍生物及其制备方法和用途 |
| CN105348170B (zh) * | 2015-11-06 | 2019-02-05 | 厦门大学 | 1-(2-(碳酰肼取代基团)-1h-吲哚-5-基)-3-取代脲衍生物及制备方法 |
| WO2018107853A2 (en) | 2016-09-26 | 2018-06-21 | Qingdao Primedicine Pharmaceutical Co., Ltd. | N-methyl-d-aspartate receptor allosteric modulators and methods for their use |
| PL233208B1 (pl) * | 2018-09-17 | 2019-09-30 | Politechnika Wroclawska | Iminowe pochodne aldehydów salicylowych i hydrazydu kwasu 4-hydroksybenzoesowego oraz sposób ich wytwarzania |
| WO2023060161A1 (en) * | 2021-10-06 | 2023-04-13 | The Research Foundation For The State University Of New York | Anti-fungals compounds targeting the synthesis of fungal sphingolipids |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB762187A (en) * | 1952-10-09 | 1956-11-28 | Bayer Ag | Metal complexes of hydrazide-hydrazones and process for producing the same |
| JPS4819628B1 (https=) * | 1969-01-07 | 1973-06-14 | ||
| US3859281A (en) * | 1971-07-01 | 1975-01-07 | American Home Prod | 2,6-dichlorobenzylidenehydrazides |
| US3829492A (en) * | 1972-02-04 | 1974-08-13 | Rohm & Haas | Fungicidal salicylaldehyde hydrazones and azines |
| US3963480A (en) * | 1973-04-11 | 1976-06-15 | Sterling Drug Inc. | Herbicidal pyrrole-2-carboxamides |
| JPS62501709A (ja) * | 1985-02-11 | 1987-07-09 | ジ・アップジョン・カンパニ− | 駆虫薬ピリジニル・アシルヒドラゾン、その使用方法および組成物 |
| US5424333A (en) * | 1985-10-21 | 1995-06-13 | Rohm And Haas Company | Anthelmintic N'-substituted-N,N'-disubstitutedhydrazines |
| US6005113A (en) * | 1996-05-15 | 1999-12-21 | Molecular Probes, Inc. | Long wavelength dyes for infrared tracing |
| JPH11106371A (ja) * | 1997-07-04 | 1999-04-20 | Nisshin Flour Milling Co Ltd | アシルヒドラゾン誘導体 |
| JP2001233767A (ja) * | 2000-02-25 | 2001-08-28 | Shionogi & Co Ltd | アポａｉ発現亢進剤 |
| WO2002102301A2 (en) * | 2000-12-07 | 2002-12-27 | Cytovia, Inc. | Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| US20040110963A1 (en) * | 2001-01-22 | 2004-06-10 | Kaspar Burri | Novel hydrazones |
| DE20108608U1 (de) * | 2001-05-23 | 2001-08-09 | Wella Ag, 64295 Darmstadt | 2,5-Diamino-benzaldehyd-Derivate und diese Verbindungen enthaltende Färbemittel |
| EP1462105A1 (en) * | 2003-03-28 | 2004-09-29 | Procorde GmbH | Activation specific inhibitors of NF-kB and method of treating inflammatory processes in cardio-vascular diseases |
| DE10348022A1 (de) * | 2003-10-15 | 2005-05-25 | Imtm Gmbh | Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| EP2022495B1 (en) * | 2006-05-31 | 2014-07-23 | Mochida Pharmaceutical Co., Ltd. | Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
-
2004
- 2004-01-30 FR FR0400913A patent/FR2865732B1/fr not_active Expired - Fee Related
-
2005
- 2005-01-31 US US10/587,697 patent/US20070161697A1/en not_active Abandoned
- 2005-01-31 PT PT05717518T patent/PT1709027E/pt unknown
- 2005-01-31 DE DE602005017007T patent/DE602005017007D1/de not_active Expired - Lifetime
- 2005-01-31 ES ES09166657T patent/ES2398479T3/es not_active Expired - Lifetime
- 2005-01-31 EP EP09166657A patent/EP2113502B1/fr not_active Expired - Lifetime
- 2005-01-31 BR BRPI0507248-4A patent/BRPI0507248A/pt not_active IP Right Cessation
- 2005-01-31 AT AT05717518T patent/ATE444961T1/de not_active IP Right Cessation
- 2005-01-31 PT PT91666578T patent/PT2113502E/pt unknown
- 2005-01-31 ZA ZA200606909A patent/ZA200606909B/en unknown
- 2005-01-31 CA CA002554439A patent/CA2554439A1/fr not_active Abandoned
- 2005-01-31 EP EP05717518A patent/EP1709027B1/fr not_active Expired - Lifetime
- 2005-01-31 WO PCT/FR2005/000199 patent/WO2005082882A1/fr not_active Ceased
- 2005-01-31 JP JP2006550247A patent/JP5047629B2/ja not_active Expired - Fee Related
- 2005-01-31 AU AU2005217174A patent/AU2005217174B2/en not_active Ceased
- 2005-01-31 ES ES05717518T patent/ES2334574T3/es not_active Expired - Lifetime
- 2005-01-31 DK DK09166657.8T patent/DK2113502T3/da active
- 2005-01-31 CN CN200580009749A patent/CN100588655C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN100588655C (zh) | 2010-02-10 |
| AU2005217174B2 (en) | 2010-04-01 |
| FR2865732B1 (fr) | 2007-10-12 |
| WO2005082882A1 (fr) | 2005-09-09 |
| EP2113502B1 (fr) | 2012-11-14 |
| EP2113502A1 (fr) | 2009-11-04 |
| PT2113502E (pt) | 2013-02-15 |
| BRPI0507248A (pt) | 2007-06-26 |
| ES2398479T3 (es) | 2013-03-19 |
| ES2334574T3 (es) | 2010-03-12 |
| PT1709027E (pt) | 2010-01-13 |
| JP5047629B2 (ja) | 2012-10-10 |
| ZA200606909B (en) | 2007-12-27 |
| ATE444961T1 (de) | 2009-10-15 |
| DE602005017007D1 (de) | 2009-11-19 |
| EP1709027B1 (fr) | 2009-10-07 |
| US20070161697A1 (en) | 2007-07-12 |
| JP2007519691A (ja) | 2007-07-19 |
| FR2865732A1 (fr) | 2005-08-05 |
| CA2554439A1 (fr) | 2005-09-09 |
| CN1950356A (zh) | 2007-04-18 |
| EP1709027A1 (fr) | 2006-10-11 |
| AU2005217174A1 (en) | 2005-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20085169L (no) | Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes | |
| DK1767535T3 (da) | Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse | |
| NO20054852L (no) | GFAT inhibitorer | |
| ATE388146T1 (de) | 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor | |
| DK2113502T3 (da) | Hydrazidforbindelser og anvendelse deraf i farmaceutiske sammensætninger til behandling af hjerte-karsygdomme | |
| NO20072930L (no) | Tripentylcitrater og deres anvendelse | |
| MY142807A (en) | Benzimidazole derivative and use thereof. | |
| JO2668B1 (en) | Isoczazolins for controlling invertebrate insects | |
| DK1221444T3 (da) | Kondenserede imidazolforbindelser og lægemidler mod diabetes mellitus | |
| NO20091858L (no) | Hydrobenzamid derivater som inhibitorer av HSP90 | |
| NO20081821L (no) | Forbindelser for behandling av metabolske forstyrrelser | |
| NO20064077L (no) | Kemokinreseptorantagonister | |
| NO20082630L (no) | Vann-opploslige benzoazepinforbindelser og farmasoytisk forbindelse | |
| RU2005108046A (ru) | 1, 2, 3-триазольные производные, обладающие бактерицидной (например, фунгицидной)активностью | |
| BRPI0610312B8 (pt) | dispositivo de assistência à caminhada | |
| JP2007519721A5 (https=) | ||
| NO983493L (no) | Nye benzimidazol-, benzoksazol- og benzotiazolforbindelser, fremgangsmÕte ved fremstilling derav og farmas°ytiske sammensetninger inneholdende slike | |
| NO20045497D0 (no) | Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater | |
| EA200300927A1 (ru) | Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов | |
| MX2010001566A (es) | Derivado de aminopirazolamida. | |
| NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
| ZA200711080B (en) | 1-(2-amino-3-(substituted alkyl)-3H-benzimidazoilymethyl)-3-substituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus | |
| NO20074346L (no) | Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20065902L (no) | 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler | |
| NO20082698L (no) | Nye derivater, deres salter og antisoppmidler inneholdende disse |